多重抗藥性結核病

Translated title of the contribution: Multidrug-Resistant Tuberculosis

許 翰琳(Han-Lin Hsu), 白 冠壬(Kuan-Jen Bai), 林 賢君(Shian-Jiun Lin), 李 俊年(Chun-Nin Lee), 余 明治(Ming-Chih Yu)

Research output: Contribution to journalReview article

Abstract

Multidrug-resistant tuberculosis (MDR-TB) is defined by bacillary resistant to at least isoniazid and rifampicin in vitro. Although a great diversity of reasons accounting for MDR-TB, poor treatment adherence of patient or inappropriate prescription of physicians are still the major causes. Implementation of DOTS (directly observed therapy, short-course) could decrease incidence of MDR-TB. For MDR-TB, prevention is best strategy. Besides, implantation of DOTS-plus also could increase cure rate. To build efficacious framework system for managing tuberculosis is an important issue to prevent and treat MDR-TB.
Original languageTraditional Chinese
Pages (from-to)524-531
Number of pages8
JournalJournal of Internal Medicine of Taiwan
Volume20
Issue number6
DOIs
Publication statusPublished - 2009

    Fingerprint

Keywords

  • 多重抗藥性結核病
  • 都治計畫
  • 進階都治計劃
  • Multidrug-resistant tuberculosis
  • Directly observed therapy, short-course
  • DOTS
  • DOTS-Plus

Cite this